The purpose of this study was to examine the eVects of vitamin D supplementation on inXammatory biomarkers in overweight and obese adults participating in a progressive resistance exercise training program. Twentythree (26.1 § 4.7 years) overweight and obese (BMI 31.3 § 3.2 kg/m 2 ) adults were randomized into a doubleblind vitamin D supplementation (Vit D 4,000 IU/day; female 5, male 5) or placebo (PL, female 7; male 6) intervention trial. Both groups performed 12 weeks (3 days/ week) of progressive resistance exercise training (three sets of eight exercises) at 70-80% of one repetition maximum. Whole-blood lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF) production as well as circulating C-reactive protein (CRP), TNF , interleukin 6 (IL-6), and alanine aminotransferase (ALT) were assessed at baseline and after the 12-week intervention. No main eVects of group or time were detected for circulating CRP, TNF , IL-6, and ALT. As expected, when PL and Vit D groups were combined, there was a signiWcant correlation between percent body fat and CRP at baseline (r = 0.45, P = 0.04), and between serum 25OHD and CRP at 12 weeks (r = 0.49, P = 0.03). The PL group had a signiWcant increase in 25 g/ml LPS + polymixin B-stimulated TNF production (P = 0.04), and both groups had a signiWcant reduction in unstimulated TNF production (P < 0.05) after the 12-week intervention. Vitamin D supplementation in healthy, overweight, and obese adults participating in a resistance training intervention did not augment exercise-induced changes in inXammatory biomarkers.
Introduction
Obesity disrupts human biological processes and creates an environment susceptible to diseases, such as type 2 diabetes and atherosclerosis (Shah et al. 2008) . The development of obesity-associated disease is in part attributed to proinXammatory cytokine production from adipocytes (Meshkani and Adeli 2009) . Further, adipokines released in obese animals induce the secretion of cytokines [e.g., tumor necrosis factor (TNF) and interleukin 6 (IL-6)] from circulating immune cells, which promote additional cytokine release following immune cell inWltration into adipose tissue (Gutierrez et al. 2009 ). InXammatory cytokines (i.e., TNF and IL-6) induce the production of C-reactive protein (CRP); an acute-phase protein that, along with TNF and IL-6, is considered a reliable biomarker of systemic inXammation, and a signiWcant contributor to the pathogenesis of disease (Dandona et al. 2004; HirschWeld and Pepys 2003) . Thus, adiposity may lead to a sustained elevation in proinXammatory cytokines that characterize systemic inXammatory stress.
Evidence suggests a link among vitamin D status [serum 25-hydroxyvitamin D (25OHD)], inXammation, and obesity (Cigolini et al. 2006; Timms et al. 2002) . For example, vitamin D deWciency associated with high levels of adipose tissue is proposed to be due to the sequestration of 25OHD in adipocytes (Blum et al. 2008; Goldner et al. 2008; Wortsman et al. 2000) . There is also data to support that vitamin D deWciency is associated with the development of certain diseases that are characterized by low-grade systemic inXammation, such as type 2 diabetes (Dandona et al. 2004; Holick 2005) . The number of diVerent cells in the immune system that express the vitamin D receptor is increasing (Mauricio et al. 1996) , and there is mounting evidence to suggest that vitamin D exerts anti-inXammatory eVects (May et al. 2004 ). For example, 1 year of vitamin D supplementation (3,320 IU/day) during weight loss induced a more pronounced decrease in circulating TNF compared to weight loss alone (Zittermann et al. 2009 ). Thus, vitamin D anti-inXammatory activity may play a role in alleviating inXammation associated with obesity, which has signiWcant implications given that inXammatory biomarkers, such as CRP, TNF , and IL-6 contribute to obesity-associated disease progression (Lechleitner et al. 2002; Romero-Corral et al. 2008) .
Similar to vitamin D supplementation, exercise training may have potent anti-inXammatory properties (Beavers and Nicklas 2011; McFarlin et al. 2004; Stewart et al. 2005 Stewart et al. , 2007 , particularly when the intensity of exercise is high. For example, a 12-week resistance training program that progressed to 85-100% of one repetition maximum (RM) signiWcantly reduced muscle TNF mRNA and protein content (Greiwe et al. 2001) . Results supporting an antiinXammatory eVect of resistance exercise after a period of moderate-to-high intensity resistance training are accumulating (Stewart et al. 2007; Timmerman et al. 2008) . One study reported a signiWcant reduction in CRP levels in sedentary individuals following resistance training compared to no change in CRP after aerobic training (Donges et al. 2010) . The authors speculate that the enhanced protein synthesis rate due to resistance training may induce the suppression of inXammatory responses that results in a more pronounced reduction in circulating CRP (Donges et al. 2010; Greiwe et al. 2001) . A large adipose tissue mass, however, has been shown to interfere with the favorable responses associated with exercise training (Sitnick et al. 2009 ). It has not been determined whether vitamin D supplementation can provide an enhanced anti-inXammatory response to progressive resistance training in overweight and obese individuals. Thus, the purpose of this study was to investigate the impact of vitamin D supplementation on inXammatory biomarkers in overweight and obese adults during participation in a progressive resistance exercise training program. We hypothesized that vitamin D supplementation during exercise training would result in a greater reduction of circulating inXammatory biomarkers compared to exercise training alone.
Methods

Subjects
Overweight and obese (BMI 25-39.9 kg/m 2 ) participants were recruited during winter months (October to March). Preliminary eligibility was determined following participation in a brief telephone screening interview. During the Wrst visit to the laboratory, participants completed a health history and a physical activity assessment by questionnaire (Topolski et al. 2006 ). Subject's height, weight, and estimated maximal oxygen consumption were also obtained (Armstrong et al. 2006) . Individuals with physical activity scores in the "low" to "very low" category coupled with maximal oxygen consumption estimations in the "below average" or lower categories were eligible for participation (Armstrong et al. 2006) . Exclusionary criteria included the use of tanning booths or other artiWcial UV light exposure, high baseline vitamin D (>600 IU/day) and calcium intake (>1,000 mg/day), plans to visit sunny/warm destinations during the study period, type 2 diabetes, history or presence of metabolic disease, history of eating disorder, presence of gastrointestinal disorders, pregnancy or lactation, use of drugs to treat obesity (last 12 weeks), use of over the counter anti-obesity agents (last 12 weeks); and recent initiation of an exercise program (last four weeks).
Eligible participants (n = 34) were randomized into the trial with 23 (12 females and 11 males) completing the requirements of the study. Of the 11 dropouts, none were related to adverse eVects due to the study interventions. All experimental procedures were approved by the Purdue University Committee on the Use of Human Research Subjects and each participant provided written informed consent.
Vitamin D supplementation
The experimental design was a double-blind, randomized, placebo-controlled vitamin D supplementation trial. Participants were matched for age, weight, BMI, and sex before randomization to consume daily either 4,000 IU vitamin D 3 (Vit D, 5 females and 5 males) or a placebo (PL, seven females and six males) that contained microcrystalline cellulose in identical capsules provided by Family Pharmacy, West Lafayette, IN. Participants were also asked to consume one calcium tablet (500 mg/tablet) per day and to refrain from consuming other supplements or medications during the 12-week trial period. Single use sunscreen packets were provided to all participants with instructions to apply the contents of four packets per day to all exposed skin surfaces. Compliance for pill consumption and sunscreen use was determined by random pill and sunscreen packet counts. All participants were asked to complete a 3-day diet record (two weekdays, one weekend day) to assess vitamin D intakes prior to participation and following the 12-week program. Dietary records were analyzed using Nutrition Data System for Research, Version 4.04, Food and Nutrient Database 28 (Minneapolis, Minnesota) by the same trained nutritionist.
Acclimation and exercise training
Participants were acclimated to the treadmill (LifeFitness Treadmills, Schiller Park, IL) and eight resistance exercises: leg extension, leg Xexion, leg press, hip adduction, hip abduction, chest press, seated row, and "lat" pull down (Keiser Equipment, Fresno, CA) during a three-session acclimation week. The acclimation protocol used in this experiment is described in detail elsewhere (Timmerman et al. 2008) . BrieXy, during the Wrst acclimation session, participants were provided with detailed instruction on proper weightlifting technique and thereafter completed an eight repetition maximum (RM) for each of the eight exercises listed above. During the second acclimation session, participants completed two sets of the eight resistance exercises at 50% of their estimated 1RM. The third acclimation session required the participants to complete a 1RM muscular strength assessment for chest press, leg press, and leg curl. The sum of chest press, leg press, and leg curl 1RMs' was calculated to assess muscular strength. Participants were required to allow at least 48 h recovery between acclimation sessions. Muscular strength tests were conducted again at the end of the resistance training program.
Participants in both groups completed a supervised 12-week (3 days/week) resistance exercise training program previously employed to assess the impact of resistive exercise on inXammation (Phillips 2010) . Each session began with a warm-up that included walking on a treadmill for 5 min and light stretching. Thereafter, participants performed three sets, at 70-80% of one repetition maximum (RM), of the eight resistance exercises listed above. For the Wrst set, participants were asked to complete eight repetitions, and for the second and third set participants completed the exercise until "momentary muscular failure", or until 15 repetitions were performed. Each training session lasted approximately 40 min. Resistance was increased each week (5-10%) based on individual performance. During each exercise session, participants were supervised to ensure that they exercised at the appropriate intensity and completed all of the assigned sets.
To control for the timing of post-exercise caloric intake, all participants were asked to consume a nutrition shake (Gatorade Performance Series: Nutrition Shake) during the hour following each exercise session. The composition of the drink (360 kcal) was fat 8 g, carbohydrate 54 g, milk protein isolate 20 g, vitamin D (100 IU), and calcium (300 mg).
Body composition
Fasting body composition was assessed in the morning following a 12-h overnight fast at baseline and after the 12-week intervention, by dual energy X-ray absorptiometry (DXA, software version 4.3e Lunar Corp, Madison, WI). All participants were asked to consume the same foods and drinks during the 24 h prior to each testing day (baseline and 12 weeks) and DXA measurements for female participants were completed during the early follicular phase. In addition, subjects were instructed to refrain from exercise, supplement intake and medications for 72 h prior to DXA measurement. For the DXA measurements, the % CV based on ten subjects measured twice for total body fat mass is 2%.
Biochemical analysis
A resting blood sample was collected at baseline and after the intervention for all participants. To standardize dietary intake prior to blood collection, all participants were asked to consume the same foods and drinks during the 24 h prior to each testing day (baseline and 12 weeks). Participants were also instructed to refrain from exercise, supplement intake, and any medications for 72 h prior to blood sampling. To control for biological diVerences during the menstrual cycle, blood collection from female participants was completed during the early follicular phase. Participants arrived at the laboratory between 0600 and 0800 hours following an overnight fast (12 h). A venous blood sample was collected in serum tubes which were maintained at room temperature for 30 min followed by the separation for serum by centrifugation at 1,500£g for 15 min. Aliquots of serum were frozen at ¡80°C until further analysis. Blood drawn into sodium heparin tubes were left at room temperature and used for same day whole-blood lipopolysaccharide (LPS) stimulation. Serum 25OHD was measured by enzyme immunoassay (Heartland Assays Inc, Ames, IA). The inter-assay coeYcient of variation was 10.5%. Serum alanine aminotransferase (ALT) was measured by kinetic UV method using the ALT (GPT) Liquid Stable Reagent according to the manufacturer's speciWcations purchased from Thermo ScientiWc (Middletown, VA). For analysis of CRP, serum samples were diluted 1:100 in assay diluent prior to analysis. CRP was measured using a commercially available high-sensitivity ELISA kit purchased from ALPCO Diagnostics (Salem, NH) according to the manufacturer's speciWcations. Baseline and 12-week samples were run on the same plate along with appropriate controls. The intra-and interassay coeYcient of variation was 4.9 and 10.5%, respectively. TNF and IL-6 were quantiWed using commercially available high-sensitivity ELISA kits purchased from ALPCO Diagnostics (Salem, NH) according to the manufacturer's speciWcations. Serum samples were diluted 1:2 in assay diluent prior to analysis. Intra-assay coeYcients of variation were <4% and inter-assay coeYcients of variation were <9%.
LPS-stimulated TNF production LPS-stimulated TNF production was quantiWed using a modiWed whole-blood procedure described originally by Zheng et al. (1997) . Whole blood was diluted 1:10 with RPMI (2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin) and treated as follows in Wve 2 ml wells: (1) 1 ng/ml LPS, (S. enteriditis, Sigma-Aldrich, St. Louis, MO); (2) 1 ng/ml LPS and 100 g/ml polymixin B (PMB); (3) 25 g/ml LPS; (4) 25 g/ml LPS and 100 g/ml PMB; and (5) 0 g/ml LPS. PMB interferes with LPS-stimulated cytokine production by binding to LPS, and thus preventing its interaction with the cell-surface of monocytes. LPS and PMB were added to the wells 15 min prior to the addition of whole blood. Plates were incubated (5% CO 2 , 37°C) for 24 h. Following the 24 h incubation, the plates were centrifuged (500£g, 10 min) and the supernatant was removed and Wltered (0.2 m). Supernatant was stored at ¡80°C until analysis for TNF using ELISA (OptEIA, BectonDickinson, San Diego, CA). The inter-assay coeYcient of variation for TNF was 10.3%.
Statistical analysis
Descriptive and univariate statistics were assessed for all variables. Assumptions of normality (Shapiro-Wilks) and homogeneity of variance (residual plots) were determined and outliers removed (>3 standard deviations from the mean). Non-normally distributed data were appropriately transformed following a diagnostic Box-Cox analysis. Assumptions of normality and homogeneity of variance were satisWed following the log transformations of CRP, TNF production from whole blood, and ALT. InXammatory biomarkers (CRP, TNF , and IL-6), TNF production from whole blood and ALT were assessed using a two-way analysis of covariance (ANCOVA) to determine cross-sectional and longitudinal diVerences. Baseline values of each variable were included as a covariate in all models. The inXuence of sex was also tested in each model and did not inXuence the results. A Tukey post hoc multiple comparison analysis was used when appropriate. Statistical analyses were performed with SAS computer software (SAS Institute, Inc., Cary, NC; Version 8.01) and SPSS 15.0. The level of P < 0.05 was used as the threshold for declaring statistical signiWcance.
Results
No signiWcant diVerences were detected at baseline for age, height, body weight, BMI, or percent body fat between the dropouts and those who completed the study. Age, height, weight, BMI, and percent body fat were similar between groups at baseline (Table 1) .
Compliance to the 12-week supplement (vitamin D or placebo) and calcium intervention for both groups was 93 and 88%, respectively. Compliance to sunscreen use was 42.5 and 40.4% in the PL and Vit D groups, respectively. Vitamin D intake was similar at baseline between the groups. Total vitamin D intake was signiWcantly higher in the Vit D group (Vit D 3,859 § 445 IU/day) compared to the PL group (215 § 213 IU/day) at the end of the 12-week intervention. There was no signiWcant diVerence in serum 25OHD levels at baseline between the groups (PL = 18.1 § 6.5 ng/ml, Vit D = 20.8 § 8.3 ng/ml), and did not increase in the PL group at 12 weeks (23.5 § 6.0 ng/ ml) compared to baseline levels. Consistent with compliance to the supplement intervention, serum levels of 25OHD at the end of the 12-week intervention were signiWcantly higher in the Vit D group (33.4 § 7.2 ng/ml) compared to the Vit D group at baseline (P = 0.003), and signiWcantly higher than the levels of the PL group at 12 weeks (P = 0.002).
Further, compliance to exercise training sessions for the vitamin D and placebo group was 96 and 97%, respectively. Consistent with this, the change in muscular strength (i.e., sum of chest press, leg press, and leg curl 1RMs') signiWcantly increased by 24.7 and 24.1% in both the PL (baseline 328.6 § 91.3 kg, 12 weeks 409.9 § 93.3 kg) and Vit D (baseline 339.0 § 93.7 kg, 12 weeks 420.9 § 101.6 kg) groups, respectively. No main eVects of group or time were found for serum CRP, TNF , and IL-6 (Table 2; Figs. 1, 2, 3 ). For the PL and Vit D groups combined, there was a signiWcant correlation between percent body fat and CRP at baseline (r = 0.45, P = 0.04). Although there was no main eVect of group on CRP at 12 weeks, for both groups combined there was a signiWcant correlation detected between serum 25OHD and CRP at 12 weeks (r = 0.49, P = 0.03). Similar results are obtained when fat mass or group are included in the model.
A main eVect of time was detected for absolute TNF production (expressed as pg/ml in culture) incubated in 1 ng/ml LPS + PMB and 25 g/ml LPS + PMB, such that the PL group had a signiWcant increase in 25 g/ml LPS + PMB TNF production following the 12-week exercise training intervention (Table 3 , P = 0.04). A main eVect of time was detected for unstimulated (no LPS), absolute TNF production such that both the PL and Vit D groups had a signiWcant reduction in absolute TNF production (P = 0.003 and P = 0.01, respectively) after the 12-week intervention (Table 3) . As expected, the addition of PMB signiWcantly blunted TNF production at both concentrations (1 ng/ml and 25 g/ml) of LPS stimulation (P < 0.05).
There were no main eVects of group or time detected for serum ALT (PL, baseline 19.4 § 17.8 pg/ml, 12 weeks 13.3 § 15.7 pg/ml; Vit D, baseline 13.7 § 12.7 U/l, 12 weeks 7.9 § 6.2 U/l).
Discussion
The results of the current study demonstrated that, in healthy overweight and obese subjects, high dose vitamin D supplementation did not inXuence circulating inXammatory biomarkers during participation in a 12-week progressive resistance exercise training program.
Circulating inXammatory biomarkers (CRP, TNF , and IL-6) were previously reported to be either decreased (Timms et al. 2002) or unchanged (Bjorkman et al. 2009; Jorde et al. 2010b; von Hurst et al. 2010 ) with vitamin D supplementation without exercise training. The results of the current study are consistent with previous Wndings that indicate no change in CRP and inXammatory cytokines after 6 months or 1 year of high dose (»4,000-5,700 IU/ day) vitamin D supplementation (Jorde et al. 2010b; von Hurst et al. 2010) . In one study, vitamin D supplementation (3,320 IU/day) reduced inXammation in obese individuals during weight loss (Zittermann et al. 2009 ). In the current study, overweight and obese participants remained weightstable during the 12-week intervention. Furthermore, there was a lower than expected increase in serum 25OHD with supplementation that may have been due to the subjects being overweight or obese (Heaney 2000; Wortsman et al. 2000) . Decreased 25OHD bioavailability with high levels of adipose tissue is also consistent with the evidence showing no eVect of high dose vitamin D supplementation in Table 2 Serum levels of CRP, TNF , and IL-6 at baseline and following the 12-week intervention No main eVects of time or group were detected (P > 0.05). Values are mean § SD CRP C-reactive protein, TNF tumor necrosis factor alpha, IL-6 interleukin 6 Placebo (n = 13) Vitamin D (n = 10) Baseline 12 weeks Baseline 12 weeks CRP (mg/l) 2.9 § 2.9 2.8 § 2.7 3.8 § 2.8 4.8 § 3.6 TNF (pg/ml) 1.9 § 1.3 1.9 § 1.2 2.3 § 1.1 2.1 § 1.2 IL-6 (pg/ml) 1.1 § 0.6 1.2 § 0.6 1.6 § 0.7 1.5 § 0.7 Fig. 1 Individual diVerences in C-reactive protein (CRP) at baseline and after 12 weeks of resistance exercise training in both the placebo (Wlled triangle) and vitamin D (Wlled circle) groups overweight and obese subjects on changes in cardiovascular risk factors, inXammation, and bone mineral density (Jorde et al. 2010a, b, c) . Thus, future work should incorporate longer supplementation with vitamin D intake and/or concomitant weight loss to test the anti-inXammatory impact in overweight and obese subjects.
There was no individual group eVect on CRP, although when the groups were combined CRP was positively correlated with 25OHD after the 12-week intervention. However, circulating levels of the liver enzyme ALT, which is elevated during hepatic stress, were unaVected by the 12-week intervention with no diVerences detected between Table 3 Monocyte TNF (pg/ml) production for PL and Vit D groups at baseline and following the 12 weeks of resistance training Whole blood was treated as follows in Wve 2 ml wells: (1) 1 ng/ml lipopolysaccharide (LPS); (2) 1 ng/ml LPS and 100 g/ml polymixin B (PMB); (3) 25 g/ml LPS; (4) 25 g/ml LPS and 100 g/ml PMB; and (5) 0 g/ml LPS. PMB interferes with LPS-stimulated tumor necrosis factor alpha (TNF ) production by binding to LPS, and thus preventing its interaction with the monocyte cell-surface. Plates were incubated for 24 h. Values are mean § SD a SigniWcant diVerence from baseline (P < 0.05). No diVerences were detected between groups (P > 0.05) Placebo (n = 13) Vitamin D (n = 10) No LPS 1.6 § 0.9 0.6 § 0.5 a 1.5 § 0.6 0.6 § 0.5 a groups. These results support that vitamin D supplementation in the current study did not lead to liver damage during the 12-week intervention and did not alter CRP levels.
The results of the current study did not show the eVect of resistance exercise training on circulating inXammatory biomarkers (CRP, TNF , and IL-6). These results are similar to other studies that report no change in either CRP (Timmerman et al. 2008) or circulating TNF , and IL-6 (Stewart et al. 2007 ) with similar exercise training regimens. In contrast, exercise-induced reductions in CRP and inXammatory cytokines are associated with weight loss (Fisher et al. 2010; Okita et al. 2004 ). In fact, it was suggested that weight loss has a more profound inXuence on reducing inXammation compared to exercise training alone (Fisher et al. 2010) , and that weight loss may be necessary to observe an exercise-induced reduction in CRP (Okita et al. 2004) . Although the participants in the current study were overweight and obese, they were otherwise apparently healthy and remained weight-stable, without any changes in body composition, throughout the 12-week intervention. Thus, exercise training interventions in conjunction with weight loss may be more likely to induce responses that are more robust than observed in individuals who remain weight-stable.
Unstimulated, absolute TNF production from whole blood was reduced in both groups after the 12-week intervention that may reXect a modest anti-inXammatory inXuence of exercise, independent of vitamin D. These Wndings, however, are diYcult to interpret given that LPS-stimulated TNF production was not reduced in either group at 12 weeks, and that the PL group had a signiWcant increase in 25 g/ml LPS + PMB, absolute TNF production following the 12-week exercise training intervention. Other investigators have implemented similar exercise training protocols to that of the current study, and report either no change (Stewart et al. 2005) or a signiWcant reduction (Timmerman et al. 2008) in LPS-stimulated TNF production from whole blood. One limitation of the current study is that LPS-stimulated TNF was reported only in absolute values (pg/ml) rather than also including TNF production relative to CD14+ monocyte, as shown in other studies that report both (Timmerman et al. 2008 ). Yet, absolute levels of LPS-stimulated TNF production tend to reveal similar results when reported relative to CD14+ monocyte (Timmerman et al. 2008 ). Another possibility is that the increase in 25 g/ml LPS-stimulated TNF production may have occurred due to normal seasonal variation (Myrianthefs et al. 2003) . Indeed, Myrianthefs et al. (2003) reported that LPS-stimulated production of TNF is lowest during autumn, compared to other seasons. Participants in the current study were recruited during late autumn/early winter and may have experienced a seasonal increase in LPSstimulated TNF during participation in winter. This is the Wrst study in which the eVects of vitamin D supplementation (4,000 IU/day) on inXammatory biomarkers in healthy, overweight, and obese adults participating in a resistance exercise training intervention have been examined. A limitation of the present study was the inclusion of healthy, overweight, and obese participants. This subject population may have a limited possibility of attaining improvements in serum 25OHD due to a decreased 25OHD bioavailability with high levels of adipose tissue compared to thinner individuals. Further, the results of this study cannot be applied to a normal weight population. Thus, future studies investigating the impact of vitamin D supplementation in conjunction with weight loss in obese individuals or comparing the response in normal weight and overweight or obese subjects while participating in a resistance exercise training program are warranted.
Conclusions
In conclusion, vitamin D supplementation in healthy, weight-stable, overweight, and obese subjects during a resistance exercise training program did not inXuence inXammatory biomarkers or induce liver damage.
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